VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 175 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $100,000 | -40.1% | 10,100 | -34.3% | 0.00% | – |
| Q2 2022 | $167,000 | -37.7% | 15,372 | -35.2% | 0.00% | – |
| Q1 2022 | $268,000 | -15.7% | 23,704 | +16.8% | 0.00% | -100.0% |
| Q4 2021 | $318,000 | -73.6% | 20,300 | -71.1% | 0.00% | -75.0% |
| Q3 2021 | $1,203,000 | +158.7% | 70,139 | +224.5% | 0.00% | +100.0% |
| Q2 2021 | $465,000 | +72.9% | 21,617 | +31.9% | 0.00% | 0.0% |
| Q4 2019 | $269,000 | -57.4% | 16,388 | -32.2% | 0.00% | -60.0% |
| Q4 2018 | $632,000 | +229.2% | 24,180 | +187.9% | 0.01% | +400.0% |
| Q3 2018 | $192,000 | -86.8% | 8,400 | -91.2% | 0.00% | -85.7% |
| Q4 2017 | $1,453,000 | +24116.7% | 95,500 | +23775.0% | 0.01% | – |
| Q1 2017 | $6,000 | -98.8% | 400 | -98.8% | 0.00% | -100.0% |
| Q4 2016 | $510,000 | +7185.7% | 32,000 | +7900.0% | 0.00% | – |
| Q3 2016 | $7,000 | -81.6% | 400 | -91.1% | 0.00% | – |
| Q1 2016 | $38,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |